ASIA News
Accenture study finds millennials, Gen Z are looking to technology, nontraditional settings for hea…
Younger generations are less likely to have a primary care doctor. However, on the whole, virtual care and walk-in clinics are on the rise.
Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population.
Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement.
Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%.
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.
The company announced last week that it had placed its One-minute Clinics across 8 provinces and cities in China and signed service contracts for nearly 1,000 units.